Superimposed epitopes restricted by the same HLA molecule drive distinct HIV-specific CD8+ T cell repertoires

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 77-84

  Sun, Xiaoming ^a   Fujiwara, Mamoru ^a   Shi, Yi ^b   Kuse, Nozomi ^a   Gatanaga, Hiroyuki ^a,c   Appay, Victor ^a,d   Gao, George F ^b   Oka, Shinichi ^a,c   Takiguchi, Masafumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d Assistance publique Hôpitaux de Paris   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A24 ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN SPECIFICITY; ANTIGEN STRUCTURE; ARTICLE; CD8+ T LYMPHOCYTE; CONFORMATION; CONTROLLED STUDY; CROSS REACTION; CRYSTALLOGRAPHY; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; JAPANESE (PEOPLE); LYMPHOCYTE FUNCTION; MOLECULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RESTRICTION; RECEPTOR AFFINITY; SEQUENCE ANALYSIS; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; CRYSTALLOGRAPHY, X-RAY; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HLA-A24 ANTIGEN; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RECEPTORS, ANTIGEN, T-CELL;

EID: 84903638866     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400375     Document Type: Article

References (53)

1. Rammensee, H. G., K. Falk, and O. Rötzschke. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11: 213-244.
2. Yewdell, J. W., E. Reits, and J. Neefjes. 2003. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat. Rev. Immunol. 3: 952-961.
3. Garcia, K. C., L. Teyton, and I. A. Wilson. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17: 369-397. (Pubitemid 29241129)
4. Choppin, J., W. Cohen, A. Bianco, J. P. Briand, F. Connan, M. Dalod, and J. G. Guillet. 2001. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J. Immunol. 166: 6164-6169. (Pubitemid 32440746)
5. Ikeda-Moore, Y., H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi. 1997. Identification and characterization of multiple HLA-A24- restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1. J. Immunol. 159: 6242-6252. (Pubitemid 127471566)
6. Le Gall, S., P. Stamegna, and B. D. Walker. 2007. Portable flanking sequences modulate CTL epitope processing. J. Clin. Invest. 117: 3563-3575. (Pubitemid 350097011)
7. Goulder, P. J., Y. Tang, S. I. Pelton, and B. D. Walker. 2000. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J. Virol. 74: 5291-5299. (Pubitemid 30313871)
8. Hashimoto, M., T. Akahoshi, H. Murakoshi, N. Ishizuka, S. Oka, and M. Takiguchi. 2012. CTL recognition of HIV-1-infected cells via cross-recognition of multiple overlapping peptides from a single 11-mer Pol sequence. Eur. J. Immunol. 42: 2621- 2631.
9. Stewart-Jones, G. B., G. Gillespie, I. M. Overton, R. Kaul, P. Roche, A. J. McMichael, S. Rowland-Jones, and E. Y. Jones. 2005. Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J. Immunol. 175: 2459- 2468.
10. Ueno, T., C. Motozono, S. Dohki, P. Mwimanzi, S. Rauch, O. T. Fackler, S. Oka, and M. Takiguchi. 2008. CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef. J. Immunol. 180: 1107-1116.
11. Saito, S., S. Ota, E. Yamada, H. Inoko, and M. Ota. 2000. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 56: 522-529. (Pubitemid 32039363)
12. Naruto, T., H. Gatanaga, G. Nelson, K. Sakai, M. Carrington, S. Oka, and M. Takiguchi. 2012. HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent. J. Virol. 86: 10870-10872.
13. Chikata, T., J. M. Carlson, Y. Tamura, M. A. Borghan, T. Naruto, M. Hashimoto, H. Murakoshi, A. Q. Le, S. Mallal, M. John, et al. 2014. Host-specific adaptation of HIV-1 subtype B in the Japanese population. J. Virol. 88: 4764-4775.
14. Sobao, Y., K. Sugi, H. Tomiyama, S. Saito, S. Fujiyama, M. Morimoto, S. Hasuike, H. Tsubouchi, K. Tanaka, and M. Takiguch. 2001. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J. Hepatol. 34: 922-929. (Pubitemid 32595194)
15. Nakamoto, Y., S. Kaneko, H. Takizawa, Y. Kikumoto, M. Takano, Y. Himeda, and K. Kobayashi. 2003. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers. J. Med. Virol. 70: 51-61. (Pubitemid 36368865)
16. Tanuma, J., M. Fujiwara, K. Teruya, S. Matsuoka, H. Yamanaka, H. Gatanaga, N. Tachikawa, Y. Kikuchi, M. Takiguchi, and S. Oka. 2008. HLA-A*2402-restricted HIV-1-specific cytotoxic T lymphocytes and escape mutation after ART with structured treatment interruptions. Microbes Infect. 10: 689-698.
17. Fujiwara, M., J. Tanuma, H. Koizumi, Y. Kawashima, K. Honda, S. Mastuoka- Aizawa, S. Dohki, S. Oka, and M. Takiguchi. 2008. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts. J. Virol. 82: 138- 147. (Pubitemid 350309131)
18. Goulder, P. J., A. Edwards, R. E. Phillips, and A. J. McMichael. 1997. Identification of a novel HLA-A24-restricted cytotoxic T-lymphocyte epitope within HIV-1 Nef. AIDS 11: 1883-1884. (Pubitemid 27500967)
19. Tanabe, M., M. Sekimata, S. Ferrone, and M. Takiguchi. 1992. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J. Immunol. 148: 3202- 3209.
20. Karaki, S., A. Kariyone, N. Kato, K. Kano, Y. Iwakura, and M. Takiguchi. 1993. HLA-B51 transgenic mice as recipients for production of polymorphic HLA-A, B-specific antibodies. Immunogenetics 37: 139-142.
21. Takamiya, Y., C. Schönbach, K. Nokihara, M. Yamaguchi, S. Ferrone, K. Kano, K. Egawa, and M. Takiguchi. 1994. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int. Immunol. 6: 255-261.
22. Zemmour, J., A. M. Little, D. J. Schendel, and P. Parham. 1992. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148: 1941- 1948.
23. Ljunggren, H. G., N. J. Stam, C. Ohlén, J. J. Neefjes, P. Höglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, K. Kärre, et al. 1990. Empty MHC class I molecules come out in the cold. Nature 346: 476-480.
24. Ibe, M., Y. I. Moore, K. Miwa, Y. Kaneko, S. Yokota, and M. Takiguchi. 1996. Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A*2402 molecules. Immunogenetics 44: 233-241. (Pubitemid 26265799)
25. Fujiwara, M., and M. Takiguchi. 2007. HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. Blood 109: 4832-4838. (Pubitemid 46827779)
26. Sun, X., M. Saito, Y. Sato, T. Chikata, T. Naruto, T. Ozawa, E. Kobayashi, H. Kishi, A. Muraguchi, and M. Takiguchi. 2012. Unbiased analysis of TCRα/b chains at the single-cell level in human CD8+ T-cell subsets. PLoS ONE 7: e40386.doi:10.1371/journal.pone.0040386
27. Lefranc, M. P., V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, et al. 2009. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37(Database issue): D1006-D1012.
28. Venturi, V., K. Kedzierska, S. J. Turner, P. C. Doherty, and M. P. Davenport. 2007. Methods for comparing the diversity of samples of the T cell receptor repertoire. J. Immunol. Methods 321: 182-195. (Pubitemid 46441208)
29. Shi, Y., J. Qi, A. Iwamoto, and G. F. Gao. 2011. Plasticity of human CD8aa binding to peptide-HLA-A*2402. Mol. Immunol. 48: 2198-2202.
30. Almeida, J. R., D. A. Price, L. Papagno, Z. A. Arkoub, D. Sauce, E. Bornstein, T. E. Asher, A. Samri, A. Schnuriger, I. Theodorou, et al. 2007. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204: 2473-2485. (Pubitemid 47529331)
31. Robins, H. S., P. V. Campregher, S. K. Srivastava, A. Wacher, C. J. Turtle, O. Kahsai, S. R. Riddell, E. H. Warren, and C. S. Carlson. 2009. Comprehensive assessment of T-cell receptor b-chain diversity in ab T cells. Blood 114: 4099- 4107.
32. van Bockel, D. J., D. A. Price, M. L. Munier, V. Venturi, T. E. Asher, K. Ladell, H. Y. Greenaway, J. Zaunders, D. C. Douek, D. A. Cooper, et al. 2011. Persistent survival of prevalent clonotypes within an immunodominant HIV gag-specific CD8+ T cell response. J. Immunol. 186: 359-371.
33. Dash, P., J. L. McClaren, T. H. Oguin, III, W. Rothwell, B. Todd, M. Y. Morris, J. Becksfort, C. Reynolds, S. A. Brown, P. C. Doherty, and P. G. Thomas. 2011. Paired analysis of TCRα and TCRβ chains at the single-cell level in mice. J. Clin. Invest. 121: 288-295.
34. Akari, H., S. Arold, T. Fukumori, T. Okazaki, K. Strebel, and A. Adachi. 2000. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74: 2907-2912. (Pubitemid 30117605)
35. Tomiyama, H., M. Fujiwara, S. Oka, and M. Takiguchi. 2005. Cutting edge: epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J. Immunol. 174: 36-40. (Pubitemid 40007389)
36. Ladell, K., M. Hashimoto, M. C. Iglesias, P. G.Wilmann, J. E. McLaren, S. Gras, T. Chikata, N. Kuse, S. Fastenackels, E. Gostick, et al. 2013. A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38: 425-436.
37. Gross, D. A., S. Graff-Dubois, P. Opolon, S. Cornet, P. Alves, A. Bennaceur- Griscelli, O. Faure, P. Guillaume, H. Firat, S. Chouaib, et al. 2004. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J. Clin. Invest. 113: 425-433.
38. Ciernik, I. F., J. A. Berzofsky, and D. P. Carbone. 1996. Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes. J. Immunol. 156: 2369-2375. (Pubitemid 26091559)
39. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
40. Willcox, B. E., G. F. Gao, J. R. Wyer, J. E. Ladbury, J. I. Bell, B. K. Jakobsen, and P. A. van der Merwe. 1999. TCR binding to peptide-MHC stabilizes a flexible recognition interface. Immunity 10: 357-365. (Pubitemid 29165290)
41. Baker, B. M., D. R. Scott, S. J. Blevins, and W. F. Hawse. 2012. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Immunol. Rev. 250: 10-31.
42. Ekeruche-Makinde, J., J. J. Miles, H. A. van den Berg, A. Skowera, D. K. Cole, G. Dolton, A. J. Schauenburg, M. P. Tan, J. M. Pentier, S. Llewellyn-Lacey, et al. 2013. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood 121: 1112-1123.
43. Turner, S. J., P. C. Doherty, J. McCluskey, and J. Rossjohn. 2006. Structural determinants of T-cell receptor bias in immunity. Nat. Rev. Immunol. 6: 883-894. (Pubitemid 44851731)
44. Kjer-Nielsen, L., C. S. Clements, A. W. Purcell, A. G. Brooks, J. C. Whisstock, S. R. Burrows, J. McCluskey, and J. Rossjohn. 2003. A structural basis for the selection of dominant ab T cell receptors in antiviral immunity. Immunity 18: 53-64. (Pubitemid 36120687)
45. Tynan, F. E., H. H. Reid, L. Kjer-Nielsen, J. J. Miles, M. C. Wilce, L. Kostenko, N. A. Borg, N. A. Williamson, T. Beddoe, A. W. Purcell, et al. 2007. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8: 268-276.
46. Stewart-Jones, G. B., A. J. McMichael, J. I. Bell, D. I. Stuart, and E. Y. Jones. 2003. A structural basis for immunodominant human T cell receptor recognition. Nat. Immunol. 4: 657-663.
47. Turner, S. J., K. Kedzierska, H. Komodromou, N. L. La Gruta, M. A. Dunstone, A. I. Webb, R. Webby, H. Walden, W. Xie, J. McCluskey, et al. 2005. Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat. Immunol. 6: 382-389. (Pubitemid 41716778)
48. Wynn, K. K., Z. Fulton, L. Cooper, S. L. Silins, S. Gras, J. K. Archbold, F. E. Tynan, J. J. Miles, J. McCluskey, S. R. Burrows, et al. 2008. Impact of clonal competition for peptide-MHC complexes on the CD8+ T-cell repertoire selection in a persistent viral infection. Blood 111: 4283-4292.
49. Cornberg, M., A. T. Chen, L. A. Wilkinson, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, R. M. Welsh, and L. K. Selin. 2006. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J. Clin. Invest. 116: 1443-1456.
50. Meyer-Olson, D., N. H. Shoukry, K. W. Brady, H. Kim, D. P. Olson, K. Hartman, A. K. Shintani, C. M. Walker, and S. A. Kalams. 2004. Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape. J. Exp. Med. 200: 307-319.
51. Kedzierska, K., N. L. La Gruta, M. P. Davenport, S. J. Turner, and P. C. Doherty. 2005. Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 102: 11432-11437.
52. Messaoudi, I., J. A. Guevara Patiño, R. Dyall, J. LeMaoult, and J. Nikolich- Zugich. 2002. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science 298: 1797-1800. (Pubitemid 35404125)
53. Appay, V., D. C. Douek, and D. A. Price. 2008. CD8+ T cell efficacy in vaccination and disease. Nat. Med. 14: 623-628. (Pubitemid 351809548)